Subscribe today to receive notice of our latest thought leadership, articles, blogs and updates.
Insights
Blogs
Sharing perspectives leads to greater understanding and fuels innovation
Check out our latest blog posts:
|
November 16, 2022 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
|
|
October 26, 2022 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
|
October 20, 2022 · Clinical Team
When it comes to unused prescription medications, the Drug Enforcement Agency (DEA) encourages everyone to “Keep them safe. Clean them out. Take them back.” They enforce this motto by sponsoring National Prescription Drug Take Back Days. Read more... |
|
|
October 05, 2022 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
|
|
September 07, 2022 · Public Policy & Regulatory Affairs Team
Brief updates on several recent policy developments across the country. Read more... |
|
|
August 17, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
July 28, 2022 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
July 14, 2022 · Clinical Team
Effective June 30, 2022, Zelnorm 6 mg tablet will no longer be produced and marketed in the United States, as announced by its manufacturer, Alfasigma USA, Inc. Read more... |
Page 8 of 10
